Atopic Dermatitis

Jeffrey Sugarman, M.D., Ph.D. provides his insight on the most significant changes in pediatric eczema treatment over the last few years.

LEO Pharma has recently announced that all three phase 3 studies examining the safety and efficacy of the atopic dermatitis investigational drug tralokinumab met all of its primary and secondary endpoints, leading way to the company now seeking marketing authorization for the drug.

Biopsies are the gold standard approach for obtaining skin samples to test for biomarkers in atopic dermatitis, but tape strips may offer a far less invasive alternative for young children with the disease, research suggests.

Dermatologists should look for signs of conjunctivitis in their atopic dermatitis patients and learn how to manage the condition because this patients population may have an increased risk of experiencing conjunctivitis, particularly allergic conjunctivitis, according to a recent study.

Atopic dermatitis can have a profound impact on the quality of life of adolescents with skin of color. A recent review discusses special considerations for this patient population.

The U.S. FDA has granted Dermira with a Fast Track designation for its atopic dermatitis drug lebrikizumab following the start of phase 3 clinical trials to examine the efficacy, tolerability and safety of the drug.

Traditional and popular treatments aimed at calming the often intense pruritus that accompanies atopic dermatitis might not be optimal therapeutic options, according to a recent review.

A new online resource called the Understand AD Squad aims to help teens navigate real-life experiences with atopic dermatitis.

Methotrexate and cyclosporine appear to have better safety profiles over a six-month period than other systemic treatments used to treat atopic dermatitis, according to a recent study.

Significant variation exists in prescribing patterns among doctors managing atopic dermatitis, and the prescription of some drugs may go against dermatology guidelines, finds a recent study.

An expert speaks with Dermatology Times about the nuances of diagnosing, treating and managing eczema in black patients.

Children with atopic dermatitis - especially moderate-to-severe disease - seem to have an risk of developing other atopic diseases, such as asthma, allergic rhinitis and food allergies, says this expert.

Patients with moderate-to-severe atopic dermatitis may have a 20% increased risk of atrial fibrillation, finds a recent study. 

For patients with atopic dermatitis, access to dermatology care appears to be best in the West and poorest in the Midwest, shows a recent study looking at disparities in access to services across the United States.

Understanding the pattern of pruritus in various autoimmune connective tissue diseases may help physicians identify different etiologies that will inform different treatment targets to alleviate the symptom, according to researchers who examined pruritus relative to disease.

A recent study showing that patients perceive inflammation-associated itch as more intense and qualitatively different than itch without inflammation suggests that dermatologists target inflammation in conditions such as atopic dermatitis.

Not treating, incorrectly treating or undertreating eyelid eczema can result in significant patient suffering. Finding the root of the problem is key to safe and effective therapy, Dr. Peter Lio says.

Lifestyle recommendations are an interesting and complex aspect of eczema care. There are many things that can impact eczema severity and are in a patient's control to a certain extent. However, offering suggestions that can actually help patients can be challenging, one expert says.

Adult atopic dermatitis patients with moderate-to-severe disease who were treated with systemic agents reported a high level of disease-related burden despite those treatments, says a recent study.

Bathing in a 0.5% apple cider vinegar solution isn’t a useful treatment for atopic dermatitis, and it can be irritating to the skin, report researchers in a recent study.

Stay up-to-date on the most recent clinical advances in atopic dermatitis.

In this interview, Dr. Anna De Benedetto discusses what initially drew her to dermatology and what inspired her to study atopic dermatitis in the elderly.